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Abstract
Sample transport and electrokinetic injection bias are well-characterized in capillary
electrophoresis and simple microchips, but a thorough understanding of sample transport on
devices combining electroosmosis, electrophoresis, and pressure-driven flow is lacking. In this
work, we evaluate the effects of electric fields from 0–300 V/cm, electrophoretic mobilities from
10−4–10−6 cm2/Vs, and pressure-driven fluid velocities from 50–250 µm/s on sample injection in a
microfluidic chemical cytometry device. By studying a continuous sample stream, we find that
increasing electric field strength and electrophoretic mobility result in improved injection and that
COMSOL simulations accurately predict sample transport. The effects of pressure-driven fluid
velocity on injection are complex, and relative concentration values lie on a surface defined by
pressure-driven flow rates. For high mobility analytes, this surface is flat, and sample injection is
robust despite fluctuations in flow rate. For lower mobility analytes, the surface becomes steeper,
and injection depends strongly on pressure-driven flow. These results indicate generally that
device design must account for analyte characteristics and specifically that this device is suited to
high mobility analytes. We demonstrate that for a suitable pair of peptides fluctuations in injection
volume are correlated; electrokinetic injection bias is minimized; and electrophoretic separation
achieved.
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1 Introduction
Chemical cytometry is an analytical technique in which a single cell is isolated and lysed
and its contents separated and detected [1]. The separation step permits quantitative
information about multiple analytes to be readily determined. Multi-analyte detection is
critical to measuring enzyme activity, determining how biochemical species co-vary, and
elucidating regulatory pathways at the level of individual cells (see, e.g., [2–3]). Each of
these analytical problems requires accurate comparisons of the abundance of many species
in a single cell, and acquisition and validation of these data by chemical cytometry demand a
thorough understanding of sample transport on the analytical platform used.
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Several microfluidic devices have been developed for single-cell analysis because
miniaturized systems facilitate low-volume sample handling and increase throughput by
automation [4–5]. Sample injection in chemical cytometry devices depends on the location
of cell lysis. In some designs, the cell is loaded into the electrophoresis channel [6–8] or
fixed at the channel entrance prior to lysis [9–11]. Analyte movement into the
electrophoresis channel occurs via application of an electric field, and all applied forces are
along the axis of the electrophoresis channel. In an alternative device design (Figure 1), the
cell is lysed while moving perpendicular to the electrophoresis channel [12–14]. This design
is favorable because low mobility cellular debris does not enter the electrophoresis channel;
however, the same physical principle that excludes low mobility debris from the
electrophoresis channel may also induce electrokinetic injection bias.
Electrokinetic injection bias occurs when one analyte is preferentially injected into the
electrophoresis channel. The magnitude of electrokinetic injection bias can be described by a
bias factor, b: the ratio of the amount of substance 1 injected, Q(1), to the amount of
substance 2 injected, Q(2).
(1)
This phenomenon has been well-characterized in both capillaries [15–16] and simple
microchips [17–19], but no detailed study of electrokinetic injection bias on chemical
cytometry microdevices has been performed to date. In capillary electrophoresis, the bias
factor can be readily calculated using the electrophoretic mobilities of the analytes (μep,1
and μep,2) and the electroosmotic mobility (μeo) [16]. However, in microfluidic devices, the
origins of electrokinetic injection bias can be more complex and depend on the injection
scheme used. For example, the orthogonal orientation of pinched injections reduces bias
compared to electrokinetic injections on capillaries, but both the loading and injection steps
contribute to some bias [19]. Similarly, gated injections are subject to multiple bias effects.
In addition to the first-order bias that occurs in capillary injections, gated injections also
result in a second-order, transradial bias because analytes of different mobility experience
different turning radii [17–18]. In microdevices designed for chemical cytometry, sample
transport is typically quite sophisticated because of the small sample volume and the need to
solubilize or remove debris after cell lysis. Consequently, sample injection and bias may be
influenced by several factors, including pressure-driven fluid velocities and variable buffer
compositions, in addition to electrokinetic effects. These factors necessitate empirical
studies and computer simulations of sample injection on these devices.
To more thoroughly understand electrokinetic injections in chemical cytometry microchips,
we have investigated sample transport using simulations and experiments with a commonly-
used device design (Figure 1) [12–14]. In this device, cells are carried through the device by
pressure-driven flow, focused to the lysis location using pressure-driven flow from a
focusing channel, and lysed. During successful operation, electrokinetic and hydrostatic
forces cause analytes of interest from the lysed cell to turn 90° and be injected into the
electrophoresis channel, while low mobility cellular debris continues down the sample
channel to waste. Using this device, we examined sample injection for three reporter
peptides used to assay Abl kinase activity (Table 1). In single-cell enzyme assays, the
amounts of unreacted and enzymatically-modified reporter peptide are quantified to
determine the activity of the enzyme of interest; however, before the relative amount of each
species can be determined, any electrokinetic injection bias introduced by the device design
and differing peptide mobilities must be known. Consequently, reporter peptides are
attractive analytes for these studies because their application to enzyme assays demands
accurate quantitation. The purpose of this study is to evaluate the effects of electric field
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strength, electrophoretic mobility, and pressure-driven flow on sample injection in a
commonly used microfluidic device for chemical cytometry.
2 Materials and Methods
2.1 Materials
Egg phosphatidylcholine (PC) and egg phosphatidylglycerol (PG) were obtained from
Avanti. Tris buffer for vesicle formation (Tris-ves) was composed of 10 mM
tris(hydroxymethyl)aminomethane (Tris) and 150 mM NaCl (pH 7.4). Small unilamellar
vesicles were prepared in Tris-ves as described previously [20]. Extracellular buffer (ECB)
was 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 135 mM NaCl, 5
mM KCl, 1 mM MgCl2, 1 mM CaCl2 and 10 mM glucose (pH 7.4). Tris buffer for
separations (Tris-sep) was 25 mM Tris (pH 8.4). PDMS prepolymer and curing agent were
obtained from Dow-Corning. Silicone tubing (3.2 mm i.d. and 6.4 mm o.d.) for reservoirs
was obtained from Cole-Parmer, and coverglass was obtained from Fisher. Silver-silver
chloride (Ag/AgCl) wire electrodes were prepared by soaking 1 mm diameter silver wire
(Alfa Aesar) in an aqueous solution of 1 M iron (III) chloride and 0.1 M hydrochloric acid
overnight.
Three reporter peptides for Abl kinase were synthesized by Anaspec, Inc. in both their
unmodified and phosphorylated forms. The peptide sequences are shown in Table 1; the
modified forms are phosphorylated at the tyrosine (Y) residue. The electrophoretic mobility
of each peptide in ECB was determined based on migration times for gated injections [21] of
each peptide on a simple cross chip. For high mobility peptides, gated injections were
performed in a PC-coated device; for low mobility peptides, the electrophoretic mobilities
were determined in the presence of higher electroosmotic flow using a device coated with
70% PC and 30% PG. To monitor pressure-driven flow in the device, Ba/F3 (mouse
leukemic) cells were loaded with Calcein red-orange acetoxymethyl ester (Invitrogen) and
fixed with 4% formaldehyde (Thermo Scientific) in phosphate buffered saline. Immediately
prior to use as flow tracers, the fixed cells were pelleted by 1 min centrifugation at 1400× g,
washed once, and resuspended in either 1 µM analyte in ECB or Tris-sep buffer.
2.2 Device fabrication and preparation
PDMS devices were prepared by soft lithography as described previously [22]. Briefly, a
10:1 mixture of PDMS prepolymer and curing agent were mixed together, degassed, cast
against a 30 µm high SU-8 master, and cured at 100 °C for 10 min on a hotplate. The
dimensions of the resulting channels are shown in Figure 1. The PDMS channels were
exposed to an oxygen plasma (Harrick, PDC-00) and irreversibly sealed to a coverglass.
Silicone tubing reservoirs were then plasma-sealed over each inlet and outlet hole [13].
Immediately after assembly, each device was filled by capillary action with small
unilamellar phosphatidylcholine vesicles, which spontaneously fused with the hydrophilic
channel walls to form a supported bilayer membrane coating [20]. Coated channels were
incubated at 4 °C for at least 1 h and up to 1 day before use. Immediately before use, the
device was flushed for 10 min with ECB to remove remaining vesicles and Tris ves buffer.
2.3 Injection experiments
At the start of each experiment, the sample reservoir was filled with 1 µM analyte in ECB;
the focusing reservoir with Tris-sep, and all other reservoirs with ECB. The sample and
focusing channel solutions also contained Calcein red-orange stained, formaldehyde-fixed
Ba/F3 cells for use as flow tracers. Gentle (50–250 µm/s) pressure-driven flow was
established in the cell and focusing channels by adjusting the fluid levels in the reservoirs.
Voltages of 0 V, ±340 V, ±680 V, and ±1020 V were applied to the electrophoresis channel
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using Ag/AgCl wire electrodes, a LabSmith HVS 448 high voltage sequencer, and
Sequencer 1.131 software. Sample transport was monitored using a 20× Plan Fluor objective
(Nikon Inc.) and a Nikon TE-300 microscope equipped for epifluorescence with FITC
(Semrock) and TRITC (G-2EC, Nikon) filters, a xenon arc lamp, and a CCD camera
(CoolSnapfx, Photometrics). Data were collected using Metafluor software (v5.0r1,
Molecular Devices, Inc.).
2.4 Image analysis
To quantify sample transport, fluorescence micrographs of the intersection were analyzed
using ImageJ [23]. The micrographs were background-subtracted using an image of the
device filled with ECB and normalized by dividing the data image by an image of the device
filled with 1 µM analyte. This normalization step corrected for variations in excitation
intensity across the field of view. Quantitative measures of fluorescence intensity were
obtained from the average counts for regions of interest in each of the three potential outlet
channels. To determine the fluid velocities in the cell and focusing channels, images of the
fixed cells were obtained using long (500 ms) exposure times. As a result, each cell
appeared in images as an extended streak. The distance traveled by a cell was equal to the
streak length minus the cell diameter, and the velocity of each cell was equal to the distance
traveled divided by the exposure time. We used cell concentrations of 106 cells/mL as an
acceptable compromise between adequately sampling the radially varying fluid velocity and
avoiding channel clogging at higher cell densities. We routinely measured 5 or more cells
per channel per field strength, so average fluid velocities in the cell and focusing channels
were determined by averaging the velocities of n ≥ 5 cells in each channel.
2.5 COMSOL simulations
COMSOL Multiphysics 3.5 was used to model sample transport in the device. Specifically,
electrophoretic transport, pressure-driven transport, and the electric field lines were modeled
using the Electrokinetic Flow, Incompressible Navier-Stokes, and Conductive Media DC
application modes, respectively. Electroosmotic flow was modeled using a predefined
coupling of the Incompressible Navier-Stokes and Conductive Media DC applications
modes in the MEMS module. For each simulation, the average peptide concentration (mol/
m3) and mass transfer rate (mol/s) were determined for each of three potential outlets: the
electrophoresis channel on either side of its intersection with the sample channel and the
waste outlet of the sample channel. The Supporting Information includes further details and
the physical parameters used for the simulations (Table S1).
3 Results and Discussion
To investigate the effects of electric field strength, electrophoretic mobility, and pressure-
driven fluid velocities on sample injection, we chose to load a continuous sample stream into
the device rather than lysing individual cells and injecting their contents. This simplified
system had several advantages: (i) effects of cell-to-cell variability in peptide loading were
eliminated, (ii) enough material was injected to image sample transport with a CCD camera,
(iii) the effects of varying field strength and fluid velocity were readily observed in real time
(Movie, Supporting Information), and (iv) variability due to the location and extent of cell
lysis was eliminated. The voltages and pressures applied to the device yielded a sample
stream with the same shape and velocity used for single cell experiments. Thus the behavior
of the sample stream should reproduce the trajectory of the sample plug produced upon cell
lysis. In this work, the effects of electric field strength and fluid velocity on sample injection
were examined empirically and used to determine the ability of COMSOL simulations to
accurately model transport on this PDMS/glass hybrid device. The effects of these
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parameters were evaluated for three peptide substrates for Abl kinase with electrophoretic
mobilities spanning three orders of magnitude from −1×10−6 to −2.83×10−4 cm2/Vs.
3.1 Effect of electric field strength
As expected, sample injection improved with increasing electric field strength for all
peptides, and the shape of the sample stream and field strength required to turn the stream
were well-modeled in COMSOL for the entire range of field strengths tested (0–300 V/cm,
Figure 2). For example, the COMSOL simulations accurately predicted the shape of the
sample stream as it turned into the electrophoresis channel (Figure 2c,g) and the flow of
buffer into the electrophoresis channel at higher field strength (Figure 2d,h). The only
consistent qualitative difference between the COMSOL simulations and the experimental
results was that the right side of the sample stream, which was not bounded by a channel
wall, was broader and more diffuse in the experimental results than in simulations. For
phosphorylated abl-sub, a second qualitative difference between the experimental and
simulated results was observed: the peptide migrated toward the anode in experiments and
toward the cathode in simulations. The unmodified and phosphorylated forms of abl-sub
have low magnitude electrophoretic mobilities that were overwhelmed by the higher
magnitude cathodic electroosmotic flow in simulations. The electrophoretic mobility of p-
abl-sub (−0.36 × 10−4 cm2/Vs) was close in magnitude and opposite in sign compared to the
electroosmotic mobility of the PC-coated channels (+0.52 ± 0.19 × 10−4 cm2/Vs). The large
standard deviation of the measured electroosmotic mobility suggested that the relative
velocities of these phenomena could not determined, and the miscalculation of migration
direction likely represented a limitation of the data rather than a failure of the simulation. In
general , we expect accurate simulations for values of μep at least one standard deviation
larger or smaller in magnitude than μeo. More precisely measured electroosmotic mobilities,
such as those obtained for glass devices, should therefore lend themselves to even more
accurate simulations.
Overall, qualitative agreement between experiments and simulations was obtained despite
differences in buffer composition. This device design has often been operated with different
buffer solutions in the cell and focusing channels [12–14]. For example, filling the focusing
channel with lower salt Tris-sep buffer reduced fouling of the waste and electrophoresis
channels compared to a device filled entirely with ECB [14], so these conditions were used
in the experiments reported here. The COMSOL models, however, were run for devices
filled entirely with ECB to simplify the simulations. To further validate our comparisons of
the experimental and simulated data, we compared experimental results for sample transport
in devices filled entirely with ECB to those obtained with Tris-sep in the focusing channel
and found minimal difference between the two conditions (Figure S2). This suggested that
Tris-sep buffer from the focusing channel did not enter the electrophoresis channel in
significant amounts; indeed, separations on this device have yielded similar migration times
and separation metrics to those performed in a simple cross chip filled with ECB-glucose
[14].
Quantitative evaluation of electrokinetic injection bias requires knowledge of the amount of
each substance injected, Q(i), or in the case of the continuous injections used here, the
amount of sample injected as a function of time, i.e., the mass transfer rate, Q(i)/t. While this
mass transfer information was readily extracted from simulations, the experimental data
consisted of fluorescence counts, which were linearly proportional to sample concentration
(R2 = 0.998). Consequently, the relative concentration of sample in the detector side of the
electrophoresis channel was calculated with Equation (2),
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where C is analyte concentration in each outlet channel. Simulated data indicated that this
value was a suitable stand-in for mass transfer data (Figure S1), so relative concentration
was used to compare experimental and simulated results.
Overall, quantitative agreement between simulations and experiments was good (Figure 3a–
c). Specifically, for moderate to high mobility analytes in the presence of an electric field,
the COMSOL models showed excellent agreement with the experimental results. For these
data, the difference between experiments and simulations ranged from 0.1% to 10%. In
contrast, COMSOL simulations systematically overestimated the amount of material
injected in the absence of an electric field (0 V/cm, Figure 3a–c) and for the low mobility
peptide abl-sub at all field strengths (Figure 3a). In the absence of an applied field, or for a
peptide with an extremely low electrophoretic mobility (μep,abl-sub = −1×10−6 cm2/Vs),
transport was dominated by pressure-driven flow and diffusion. We suspect that the
discrepancy between the simulated and experimental results at low values of E and μep
resulted from underestimation of the sample stream broadening in COMSOL (Figure 2 and
Supporting Information). Notably, COMSOL accurately predicted the relative effect of
increasing electric field strength on abl-sub injection: although the simulated results were
offset from the experimental data, the two plots possessed the same slope (Figure 3a).
3.2 Effect of analyte electrophoretic mobility: comparing reporter peptides
The Abl kinase reporter peptides studied here – abl-sub [24], QW-V-48B (manuscript in
preparation), and NCMK-1 – represent a range of electrophoretic mobilities spanning three
orders of magnitude. Consequently, we were able to evaluate the effect of analyte mobility
on sample injection. All three peptides and their phosphorylated forms were roughly the
same size (MW = 1166 – 1774 Da) and were calculated to have similar diffusion
coefficients (Supporting Information). As a result, in the absence of an electric field, sample
injection into the electrophoresis channel was statistically the same for all peptides (p =
0.353, one-way ANOVA). When voltage was applied, the peptides’ different electrophoretic
mobilities resulted in different transport profiles.
Although the relative concentration data in Figure 3a–c was useful for comparing
experimental and simulated results, the mass transfer rate in each channel, Q(i)/t, was
necessary to determine the expected electrokinetic injection bias for the three reporter
peptides. Relative mass transfer rates from the simulations were defined as the rate of
sample transfer toward the detector divided by the total sample transfer rate toward all three
potential outlets (Figure 3d–f). Notably, the unmodified forms of abl-sub and QW-V-48B
migrated toward the cathode, while the phosphorylated forms migrated toward the anode. As
a result, favorable electric field conditions for injecting one form of either peptide were
unfavorable for the other form, resulting in a high degree of electrokinetic injection bias
(Figure 3d, e). For example, at a field strength of +300 V/cm and fluid velocities of 150 µm/
s, the bias factors, b, for abl-sub and QW-V-48B and their phosphorylated forms would be
2.55 and 109, respectively. The electrokinetic injection bias for QW-V-48B is excessive at
+300 V/cm because the phosphorylated form loads well while the unmodified form of the
peptide effectively does not enter the electrophoresis channel. At lower field strengths (±100
V/cm), small amounts (20–50%) of both peptides enter the electrophoresis channel, but in a
mass-limited sample, such as a single-cell lysate, this degree of sample loss is unacceptable.
Consequently, both abl-sub and QW-V-48B would make poor reporters for Abl kinase on
the device used here.
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Results for the peptide NCMK-1 (Figure 3c, f) were much more promising. The unmodified
and phosphorylated forms of NCMK-1 both migrated toward the anode; the relative
concentration of peptide in the electrophoresis channel was more reproducible; and both
forms of the peptide were efficiently directed toward the detector at moderate field strength.
Additionally, despite the fact that the unmodified and phosphorylated forms had different
electrophoretic mobilities, both peptides were sufficiently mobile to be almost completely
injected into the electrophoresis channel, and electrokinetic injection bias was minimal
(Figure 3f). For example, at 300 V/cm, the experimental ratio of the relative concentration of
NCMK-1 to p-NCMK-1 was 0.9995. In simulations, the same conditions corresponded to
87% of NCMK-1 and 100% of the p-NCMK-1 being transferred into the electrophoresis
channel (Figure 3f, b = 0.87).
3.3 Effects of pressure-driven fluid velocities
To investigate the effects of hydrodynamic fluid velocities on sample injection, we
compared experimental and simulated results for the phosphorylated forms of each peptide
at fluid velocities from 50–250 µm/s in the sample and focusing channels and a constant
electric field strength of +300 V/cm. A previous report on a similar device suggested that
efficient sample injection required that the analyte’s electrokinetic velocity (νek) be greater
than its pressure-driven velocity (u) [12]. Indeed, the relative magnitudes of the sample’s
hydrodynamic and electrokinetic velocities contributed to injection efficiency; however, the
relationship between these parameters was complex.
For a fixed electric field strength of +300 V/cm, the sample and focusing channel velocities
determined the analyte’s location on a relative concentration surface (Figure 3g–i). For
lower mobility analytes, including p-abl-sub (Figure 3g) and p-QW-V-48B (Figure 3h), this
surface was fairly steep. As expected from previous work, increasing pressure-driven fluid
velocity in the sample channel negatively affected sample injection. In fact, this was true
even when the sample’s hydrodynamic velocity (u) was less than its electrokinetic velocity
(Figure 3h). In contrast, higher focusing channel velocities (v) corresponding to improved
sample injection. Presumably this occurred because flow from the focusing channel diverted
the sample channel stream, bringing it closer to the entrance of the electrophoresis channel.
Similar trends were observed for a higher mobility analyte, p-NCMK-1 (Figure 3i), but the
relative concentration surface was fairly flat. Relative concentration only dropped off at very
high sample channel velocities (~250 µm/s) and very low focusing channel velocities (~50
µm/s).
Because the relative concentration surface was steeper for low mobility analytes, their
transport was more susceptible to fluctuations in pressure-driven flow. Indeed, these results
(Figure 3g,h) suggested that variation in pressure-driven fluid velocities contributed to
variation in relative concentration and explained in part the large error bars for some data in
Figure 3a,b. For example, if we assume fluid velocities in the sample and focusing channels
of 135–165 µm/s (i.e., 20% variation around an average velocity of 150 µm/s), p-abl-sub
transport would vary by 11%. The same variation in fluid velocities would result in only
0.02% variation in p-NCMK-1 transport. We conclude that this device design is best suited
to analytes with high electrophoretic mobilities; these molecules were efficiently injected
into the electrophoresis channel with minimal bias and were less susceptible to variations in
pressure-driven fluid flow.
3.4. Simultaneous injection of two peptides
In single-cell enzyme assays, the unmodified and phosphorylated forms of a reporter peptide
are released from the lysed cell, injected into the electrophoresis channel, separated, and
detected. The ratio of the peak areas of the unmodified and phosphorylated forms is then
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used to determine enzyme activity. As a result, peptides must be injected with minimal bias
with respect to each other (b ≈ 1), and the relative amount of each peptide injected must be
stable in time (i.e., b must be stable) so that ratiometric signals from numerous cells can be
compared. We therefore evaluated the bias factor, b, as a function of time for two related
peptides: 5-FAM-labeled NCMK-1 (NCMK-1) and 5-TAMRA-labeled p-NCMK-1 (p-T-
NCMK-1) (Figure 4a). The spectrally-resolved fluorescent labels allowed us to measure
sample transport for two peptides on the same device at the same time. The bulky, neutral
TAMRA label slightly decreased the mobility of p-T-NCMK-1 relative to that of FAM-
labeled p-NCMK-1 (μep, p-T-NCMK-1 = −2.43 × 10−4 cm2/Vs, μep, p-NCMK-1 = −2.83 × 10−4
cm2/Vs); however, the comparison of NCMK-1 and p-T-NCMK-1 still provided valuable
information about how transport of two related peptides co-varied on the device. The results
indicated minimal bias for injections of these two peptides (b = 0.99 ± 0.02). Additionally,
while the relative concentrations of both peptides fluctuated with time (RSDNCMK-1 = 2.4%,
RSDp-T-NCMK-1 = 3.6%), the fluctuations were similar in magnitude and direction for both
peptides. As a result, variation in the bias factor, b, was alleviated by correlation between the
fluctuations in the two peptides’ transport (RSD = 2.0%).
While electrokinetic injection bias is eliminated by minimizing difference in analyte
electrophoretic mobility, subsequent electrophoretic separation depends on this difference to
resolve analytes. Both NCMK-1 and p-NCMK-1 were sufficiently mobile to be almost
completely injected into the electrophoresis channel at a field strength of +300 V/cm (Figure
3c, f). To confirm that the difference in their electrophoretic mobilities was sufficient for
electrophoretic separations on-chip, we separated unmodified and phosphorylated NCMK-1
in ECB on a PC-coated simple cross chip (Figure 4b). For an electric field strength of 110
V/cm, the two peptides were baseline resolved at a detection point 5 mm from the injection
intersection.
4 Concluding Remarks
Although a few multi-purpose microfluidic devices have been demonstrated (e.g., [24]),
most microdevices are still designed for specific assays of specific analytes. In some cases,
researchers optimize a device using convenient model analytes, such as fluorescent dyes,
with the goal of eventually applying the optimized design to biologically-relevant analytes
[12,14]. This strategy is only effective, however, if the analytes-of-interest are sufficiently
similar to the model analytes. The results presented here demonstrate the utility of
COMSOL modeling in answering this question. Additionally, this work demonstrates that
this device, optimized for separation of small, highly charged fluorescent dyes, is best-suited
to analysis of high electrophoretic mobility analytes (μep ≥ ± 1.5 × 10−4 cm2/Vs) at
moderate to high field strengths (≥ 300 V/cm). Lower mobility analytes are not effectively
injected into the electrophoresis channel, and these analytes are more susceptible to
electrokinetic injection bias and fluctuations in pressure-driven flow. This effect could
potentially be offset by an increase in electroosmotic flow at the expense of discrimination
between analytes and cellular debris. In general, these results demonstrate that thoughtful
pairing of device design with analyte characteristics is necessary as more microanalysis
systems graduate from model analytes to real-world applications.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Schematic of the device design with channel widths and physical parameters. The arrows u
and v indicate the direction, but not necessarily the magnitude, of pressure-driven flow in
the sample and focusing channels, respectively. The gap between the focusing channel and
the electrophoresis channel was 50 µm. All channels were 30 µm deep. Sample
concentration was evaluated in the three potential exit channels for the sample stream: the
electrophoresis channel at either side of its intersection with the sample channel and in the
waste side of the sample channel.
Kovarik et al. Page 10











(a–d) Experimental and (e–h) simulated results showed good qualitative agreement for
electric field strengths of 0–300 V/cm, as evidence by p-NCMK-1 peptide transport at (a, e)
0 V/cm, (b, f) +100 V/cm, (c, g) +200 V/cm, and (d, h) +300 V/cm. For the experimental
data, the pressure-driven fluid velocities in the sample and focusing channels were ~100 µm/
s and ~225 µm/s, respectively. For the simulations, the fluid velocity in both channels was
150 µm/s. The micrographs in (a–d) were background subtracted, normalized, and set to the
same brightness/contrast scale. The scale bar is 200 µm.
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Sample injection as a function of electric field strength (a–f) and fluid velocities (g–i). In all
plots, circles represent experimental data; squares are simulated data; and unmodified and
phosphorylated (p-) peptides are shown using open and filled symbols, respectively. (a–c)
Overall, simulated and experimental results showed good agreement on the effect of electric
field strength on sample injection. Error bars show the standard deviation for n = 4–6 runs
total on at least three different devices. (d–f) The simulated mass transfer rates demonstrate
the profound effect of electrophoretic mobility on sample transport and were used to
determine electrokinetic injection bias. (g–i) The effects of sample (v) and focusing channel
(u) velocities on the relative concentrations of the phosphorylated peptides, (g) p-abl-sub
(νek = 50 µm/s), (h) p-QW-V-48B (νek = 120 µm/s), and (i) p-NCMK-1 (νek = 690 µm/s),
are shown for a fixed field strength of +300 V/cm. The wire frame surfaces represent data
simulated in COMSOL, and the solid black circles are individual experimental runs. Drop
lines indicate the fluid velocities for each experimental point, which were determined using
fixed, stained cells as flow tracers.
Kovarik et al. Page 12











(a) Stability of peptide transport (circles) and injection ratio (triangles) as a function of time
for unmodified and phosphorylated (p-)NCMK-1 at +300 V/cm. The unmodified peptide
(open) was labeled with 5-carboxyfluorescein (FAM), and the phosphorylated peptide
(filled) was labeled with 5-carboxytetramethylrhodamine (TAMRA). The relative
concentration of each peptide in the electrophoresis channel is reported on the left axis, and
the ratio of the two signals is given on the right axis. (b) Electropherogram of 1 µM
NCMK-1 and 1 µM p-NCMK-1 in ECB on a PC-coated simple cross chip. The electric field
strength was 110 V/cm, and the detection point was 5 mm from the injection cross.
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Table 1
Reporter peptides for Abl kinase.
Name Sequencea) μep (× 10−4 cm2/Vs)
(unmodified form)
μep (× 10−4 cm2/Vs)
(phosphorylated form)
abl-sub 5-FAM-EAIYAAPFAKKK-NH2 −0.01 −0.36
QZ-V-48B 5-FAM-GGIYAAP(NMe)FKKKA-NH2 +0.37 −0.93
NCMK-1 5-FAM-GGIYAAP(NMe)F-NH2 −1.48 −2.83
a)
(NMe)F = N-methylphenylalanine
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